Influence of Extracorporeal Circulation on the Development of OSA (Obstructive Sleep Apnea)
NCT ID: NCT03743090
Last Updated: 2020-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2019-08-01
2020-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* 2\. OSA (Obstructive Sleep Apnea) could be influenced by in intravenous perfusion.
* 3\. ECC could influence the amount of intravenous perfusion administered to the patient.
The aim of this study was to examine the influence of ECC on the development of OSA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Output Monitoring With Estimated Continuous Cardiac Output (esCCO) vs. Transpulmonary Thermodilution (TPTD)
NCT02352324
Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery
NCT06728605
Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation
NCT03508505
Cardiovascular, Pulmonary and Skeletal Muscle Evaluation Postoperative in Fontan Patients: Effects of Exercise Training
NCT02283255
Usefulness of Cardiopulmonary Exercise Testing for Cardiovascular Risk Estimation and Frailty Assessment in Liver Transplant Candidates
NCT04543825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* 2\. OSA (Obstructive Sleep Apnea) could be influenced by in intravenous perfusion.
* 3\. ECC could influence the amount of intravenous perfusion administered to the patient.
The aim of this study was to examine the influence of ECC on the development of OSA. The AHI (Apnea Hypopnea Index) will be used to assess this potential influence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CABG with ECC
Group of patients for whom CABG was performed under ECC. A polysomnography will be performed to all of these patients the day before surgery and the third postoperative day.
Polysomnography.
A polysomnography will be performed for all of the patients the day before surgery (value of reference), and on the second postoperative day (in order to examine the influence of ECC on the development of OSA).
CABG without ECC
Group of patients for whom CABG was performed without ECC. A polysomnography will be performed to all of these patients the day before surgery and the third postoperative day.
Polysomnography.
A polysomnography will be performed for all of the patients the day before surgery (value of reference), and on the second postoperative day (in order to examine the influence of ECC on the development of OSA).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polysomnography.
A polysomnography will be performed for all of the patients the day before surgery (value of reference), and on the second postoperative day (in order to examine the influence of ECC on the development of OSA).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric DEFLANDRE, MD, PhD, FCCP, FAHA
Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric DEFLANDRE, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Astes
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OSACS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.